Berenberg Bank set a €93.00 ($108.14) price objective on Carl Zeiss Meditec (ETR:AFX) in a research report released on Friday, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.
Several other equities research analysts also recently weighed in on AFX. Hauck & Aufhaeuser set a €110.00 ($127.91) price target on shares of Carl Zeiss Meditec and gave the company a buy rating in a research report on Thursday, October 24th. HSBC set a €98.00 ($113.95) price objective on Carl Zeiss Meditec and gave the company a neutral rating in a research report on Tuesday, September 17th. Deutsche Bank set a €89.00 ($103.49) target price on Carl Zeiss Meditec and gave the company a neutral rating in a research note on Monday, August 12th. Independent Research set a €89.00 ($103.49) target price on Carl Zeiss Meditec and gave the stock a sell rating in a report on Thursday, October 24th. Finally, Kepler Capital Markets set a €80.00 ($93.02) target price on Carl Zeiss Meditec and gave the stock a sell rating in a report on Friday. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the company. The company currently has an average rating of Hold and a consensus target price of €93.86 ($109.14).
Shares of Carl Zeiss Meditec stock opened at €103.10 ($119.88) on Friday. The company has a 50-day simple moving average of €103.13 and a two-hundred day simple moving average of €97.41. The stock has a market capitalization of $9.22 billion and a PE ratio of 60.22. Carl Zeiss Meditec has a 52-week low of €65.80 ($76.51) and a 52-week high of €112.70 ($131.05). The company has a debt-to-equity ratio of 4.55, a quick ratio of 3.09 and a current ratio of 4.11.
Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.
Further Reading: When can a hold rating present a buying opportunity?
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.